Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Pertussis Response to Tdap (8 mcg/dose of the Pertussis Toxoid (PT) In Recipients of Allogeneic Hematopoietic Stem Cell Transplants (Allo HSCT).

Esperanza Papadopoulos, MD, Christine Scurra Iovino, APRN-BC, FNP-C, Molly Knowles, BA, Juliet Barker, MBBS, (Hons), FRACP, Andromachi Scaradavou, MD, Nancy A Kernan, MD, Trudy N Small, M.D

Blood (2010) 116 (21): 1282.

https://doi.org/10.1182/blood.V116.21.1282.1282

Published: 2010

Journal Articles

Vaccine Response In Recipients of HLA Mismatched Unrelated Double Unit Cord Blood Transplantation (CBT).

Trudy N Small, M.D, Christine Scura Iovino, APRN-BC, FNP-C, Michelle Abboud, RN, BSN, OCN, Marissa Lubin, BA, Esperanza Papadopoulos, MD, Andromachi Scaradavou, MD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2010) 116 (21): 1247.

https://doi.org/10.1182/blood.V116.21.1247.1247

Published: 2010

Journal Articles

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

Susan Prockop, MD, Ekaterina Doubrovina, MD, PhD, Farid Boulad, MD, Nancy A Kernan, MD, Rachel Kobos, MD, Andromachi Scaradavou, Trudy N Small, M.D, Ramzi Khalaf, Juliet Barker, MBBS, (Hons), FRACP, Guenther Koehne, MD, Esperanza Papadopoulos, MD, James W. Young, MD, Richard J. O'Reilly, MD

Blood (2010) 116 (21): 487.

https://doi.org/10.1182/blood.V116.21.487.487

Published: 2010

Journal Articles

Thrombolytic Therapy for Reversal of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH)

David J Araten, MD, Rosario Notaro, MD, Nancy A Kernan, MD, Farid Boulad, MD, Hugo Castro-Malaspina, MD, Trudy N Small, M.D, Andromachi Scaradavou, MD, Heather Magnan, MD, Susan E Prockop, MD, Sara Chaffee, MD, Jason Gonsky, MD, PhD, Raymond Thertulien, MD, PhD, Roberto Tarquini, MD, Lucio Luzzatto, MD

Blood (2010) 116 (21): 4239.

https://doi.org/10.1182/blood.V116.21.4239.4239

Published: 2010

Journal Articles

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Farid Boulad, MD, Nancy A Kernan, MD, Susan E Prockop, MD, Andromachi Scaradavou, MD, Trudy N Small, M.D, Elizabeth G Klein, Juliet Barker, MBBS, (Hons), FRACP, Ann A. Jakubowski, MD, PhD, Guenther Koehne, MD, Esperanza Papadopoulos, MD, Miguel-Angel Perales, MD, James W. Young, MD, Richard J. O'Reilly, MD

Blood (2010) 116 (21): 2354.

https://doi.org/10.1182/blood.V116.21.2354.2354

Published: 2010

Journal Articles

Induction of Remission Prior to Transplantation Improves the Disease-Free Survival (DFS) of Patients with Advanced Myelodysplastic Syndromes (MDS) Treated with Myeloablative T - Cell Depleted (TCD) Stem Cell Transplants (SCT) from Histocompatible Unrelated Donors.

H.R. Castro-Malaspina, MD, Ann A. Jakubowski, M.D., Esperanza B. Papadopoulos, M.D., Farid Boulad, M.D., James W. Young, M.D., Nancy A. Kernan, M.D., Miguel-Angel Perales, M.D., Trudy N. Small, M.D., Michelle Chiu, Glenn Heller, Ph.D., Marcel Van Den Brink, M.D., Stephen D. Nimer, M.D., Richard J. O’Reilly, M.D.

Blood (2006) 108 (11): 4859.

https://doi.org/10.1182/blood.V108.11.4859.4859

Published: 2006

NARROW

Pertussis Response to Tdap (8 mcg/dose of the Pertussis Toxoid (PT) In Recipients of Allogeneic Hematopoietic Stem Cell Transplants (Allo HSCT).

Vaccine Response In Recipients of HLA Mismatched Unrelated Double Unit Cord Blood Transplantation (CBT).

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

Thrombolytic Therapy for Reversal of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH)

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Induction of Remission Prior to Transplantation Improves the Disease-Free Survival (DFS) of Patients with Advanced Myelodysplastic Syndromes (MDS) Treated with Myeloablative T - Cell Depleted (TCD) Stem Cell Transplants (SCT) from Histocompatible Unrelated Donors.

Email alerts

ASH Publications

American Society of Hematology

Pertussis Response to Tdap (8 mcg/dose of the Pertussis Toxoid (PT) In Recipients of Allogeneic Hematopoietic Stem Cell Transplants (Allo HSCT).

Vaccine Response In Recipients of HLA Mismatched Unrelated Double Unit Cord Blood Transplantation (CBT).

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

Thrombolytic Therapy for Reversal of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH)

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Induction of Remission Prior to Transplantation Improves the Disease-Free Survival (DFS) of Patients with Advanced Myelodysplastic Syndromes (MDS) Treated with Myeloablative T - Cell Depleted (TCD) Stem Cell Transplants (SCT) from Histocompatible Unrelated Donors.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only